Avoro Capital Advisors’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Avoro Capital Advisors’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,301,718	Closed	-$94.2M	–	50
2018 Q3	$94.2M	Sell	5,301,718 -393,482	-7%	-$6.76M	4.32%	9
2018 Q2	$78.6M	Hold	5,695,200	–	–	3.03%	10
2018 Q1	$51.8M	Buy	+5,695,200	New	+$31.4M	2.47%	17

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $830M AUM 21.8% 1-Year Est. Return

Avoro Capital Advisors's ECYT Position: Q4 2018 in Review

Avoro Capital Advisors sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 5,301,718 shares — an estimated $94.2M sold.

Avoro Capital Advisors first reported a position in ECYT in Q1 2018 and held it in 3 quarters. The position peaked at $94.2M in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Avoro Capital Advisors reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Avoro Capital Advisors sold 5,301,718 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $94.2M.
Avoro Capital Advisors first reported a position in Endocyte, Inc. Common Stock in Q1 2018 and held it in 3 quarters.
Avoro Capital Advisors's Endocyte, Inc. Common Stock position peaked at $94.2M in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Avoro Capital Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.